valsartan has been researched along with Hyperplasia, Reactive Lymphoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukamachi, S; Kawakami, C; Nakamura, M; Sawada, Y; Sugita, K; Tokura, Y; Yoshiki, R | 1 |
| Mutasim, DF | 1 |
2 other study(ies) available for valsartan and Hyperplasia, Reactive Lymphoid
| Article | Year |
|---|---|
Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.
Topics: Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antihypertensive Agents; Betamethasone; Biopsy; Combined Modality Therapy; Drug Eruptions; Humans; Immunohistochemistry; Ki-1 Antigen; Male; Prednisolone; Pseudolymphoma; Skin; Tetrazoles; Treatment Outcome; Ultraviolet Therapy; Valine; Valsartan | 2010 |
Lymphomatoid drug eruption mimicking digitate dermatosis: cross reactivity between two drugs that suppress angiotensin II function.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diagnosis, Differential; Drug Eruptions; Hand Dermatoses; Humans; Lisinopril; Male; Pseudolymphoma; Tetrazoles; Valine; Valsartan | 2003 |